Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia

Abstract

Prophylactic treatment with levofloxacin is an effective and well-tolerated way of preventing febrile episodes and other relevant infection-related outcomes in patients with cancer and profound and protracted neutropenia. The long-term effect of this intervention on microbial resistance in the community is not known.